Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina

DOI record: { "DOI": "10.1097/mjt.0000000000001433", "ISSN": [ "1075-2765" ], "URL": "http://dx.doi.org/10.1097/MJT.0000000000001433", "author": [ { "affiliation": [], "family": "Chahla", "given": "Rossana E.", "sequence": "first" }, { "affiliation": [], "family": "Medina Ruiz", "given": "Luis", "sequence": "additional" }, { "affiliation": [], "family": "Ortega", "given": "Eugenia S.", "sequence": "additional" }, { "affiliation": [], "family": "Morales, RN", "given": "Marcelo F.", "sequence": "additional" }, { "affiliation": [], "family": "Barreiro", "given": "Francisco", "sequence": "additional" }, { "affiliation": [], "family": "George", "given": "Alexia", "sequence": "additional" }, { "affiliation": [], "family": "Mancilla, RN", "given": "Cesar", "sequence": "additional" }, { "affiliation": [], "family": "D' Amato, RN", "given": "Sylvia", "sequence": "additional" }, { "affiliation": [], "family": "Barrenechea", "given": "Guillermo", "sequence": "additional" }, { "affiliation": [], "family": "Goroso", "given": "Daniel G.", "sequence": "additional" }, { "affiliation": [], "family": "Peral de Bruno", "given": "Maria", "sequence": "additional" } ], "container-title": "American Journal of Therapeutics", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2021, 9, 2 ] ], "date-time": "2021-09-02T00:35:39Z", "timestamp": 1630542939000 }, "deposited": { "date-parts": [ [ 2021, 9, 7 ] ], "date-time": "2021-09-07T20:00:46Z", "timestamp": 1631044846000 }, "indexed": { "date-parts": [ [ 2022, 7, 11 ] ], "date-time": "2022-07-11T06:51:07Z", "timestamp": 1657522267235 }, "is-referenced-by-count": 5, "issue": "5", "issued": { "date-parts": [ [ 2021, 8, 16 ] ] }, "journal-issue": { "issue": "5", "published-print": { "date-parts": [ [ 2021 ] ] } }, "language": "en", "link": [ { "URL": "https://journals.lww.com/10.1097/MJT.0000000000001433", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "276", "original-title": [], "page": "e601-e604", "prefix": "10.1097", "published": { "date-parts": [ [ 2021, 8, 16 ] ] }, "published-online": { "date-parts": [ [ 2021, 9 ] ] }, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "reference": [ { "DOI": "10.1038/448645a", "article-title": "New uses for old drugs", "author": "Chong", "doi-asserted-by": "crossref", "first-page": "645", "journal-title": "Nature.", "key": "R1-20210907", "volume": "448", "year": "2007" }, { "DOI": "10.1016/j.drudis.2012.08.005", "article-title": "In silico drug repositioning: what we need to know", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "110", "journal-title": "Drug Discov Today", "key": "R2-20210907", "volume": "18", "year": "2013" }, { "DOI": "10.1038/nrd1468", "article-title": "Drug repositioning: identifying and developing new uses for existing drugs", "author": "Ashburn", "doi-asserted-by": "crossref", "first-page": "673", "journal-title": "Nat Rev Drug Discov.", "key": "R3-20210907", "volume": "3", "year": "2004" }, { "DOI": "10.1016/j.antiviral.2012.06.008", "article-title": "Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?", "author": "Caly", "doi-asserted-by": "crossref", "first-page": "202", "journal-title": "Antivir Res", "key": "R4-20210907", "volume": "95", "year": "2012" }, { "DOI": "10.1016/j.antiviral.2020.104787", "article-title": "Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect , the company' s public news and information", "author": "Caly", "doi-asserted-by": "crossref", "first-page": "104787", "journal-title": "Antivir Res", "key": "R5-20210907", "volume": "178", "year": "2020" }, { "DOI": "10.1097/MJT.0000000000001377", "article-title": "Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19", "author": "Kory", "doi-asserted-by": "crossref", "first-page": "e299", "journal-title": "Am J Ther.", "key": "R6-20210907", "volume": "28", "year": "2021" }, { "DOI": "10.1016/j.eclinm.2020.100720", "article-title": "The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial", "author": "Chaccour", "doi-asserted-by": "crossref", "first-page": "100720", "journal-title": "EClinicalMedicine.", "key": "R7-20210907", "volume": "3", "year": "2021" }, { "DOI": "10.1016/j.eclinm.2021.100959", "article-title": "Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial", "author": "Krolewiecki", "doi-asserted-by": "crossref", "first-page": "100959", "journal-title": "EClinicalMedicine.", "key": "R8-20210907", "volume": "37", "year": "2021" }, { "DOI": "10.31546/2633-8653.1007", "article-title": "Study of the efficacy and safety of topical ivermectin + iota-carrageenan in the prophylaxis against COVID-19 in health personnel", "author": "Héctor", "doi-asserted-by": "crossref", "first-page": "1007", "journal-title": "J Biomed Res Clin Investig.", "key": "R9-20210907", "volume": "2", "year": "2020" }, { "article-title": "Ivermectin as pre-exposure prophylaxis for COVID-19 among healthcare providers in a selected tertiary hospital in dhaka—an observational study", "author": "Alam", "first-page": "1", "journal-title": "Eur J Med Heal Sci.", "key": "R10-20210907", "volume": "2", "year": "2020" }, { "article-title": "Use of ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt: a randomized clinical trial", "author": "Shouman", "first-page": "27", "journal-title": "J Clin Diagn Res.", "key": "R11-20210907", "volume": "15", "year": "2021" }, { "article-title": "Prophylaxis covid-19 in health workers through intensive treatment with ivermectin and iota-carrageenan (Ivercar-Tuc)", "author": "Chahla", "first-page": "NCT047017", "journal-title": "ClinicalTrials.gov.", "key": "R12-20210907", "volume": "20", "year": "2020" }, { "DOI": "10.1186/s13063-020-04421-z", "article-title": "The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: a structured summary of a study protocol", "author": "Chaccour", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Trials", "key": "R13-20210907", "volume": "21", "year": "2020" }, { "article-title": "Covid 19 and ivermectin prevention and treatment update", "author": "Hirsch", "first-page": "1", "journal-title": "J Infect Dis Trav Med.", "key": "R14-20210907", "volume": "4", "year": "2020" }, { "article-title": "Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study [published online ahead of print, 2021 Jun 2]", "author": "Abd-Elsalam", "journal-title": "J Med Virol.", "key": "R15-20210907", "year": "2021" }, { "DOI": "10.1186/s12941-020-00368-w", "article-title": "Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19", "author": "Sharun", "doi-asserted-by": "crossref", "first-page": "23", "journal-title": "Ann Clin Microbiol Antimicrob.", "key": "R16-20210907", "volume": "19", "year": "2020" }, { "DOI": "10.3906/sag-2004-145", "article-title": "Antiviral treatment of covid-19", "author": "Şimşek Yavuz", "doi-asserted-by": "crossref", "first-page": "611", "journal-title": "Turkish J Med Sci.", "key": "R17-20210907", "volume": "50", "year": "2020" }, { "DOI": "10.1097/MJT.0000000000001402", "article-title": "Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines", "author": "Bryant", "doi-asserted-by": "crossref", "first-page": "e434", "journal-title": "Am J Ther.", "key": "R18-20210907", "volume": "28", "year": "2021" } ], "reference-count": 18, "references-count": 18, "relation": {}, "resource": { "primary": { "URL": "https://journals.lww.com/10.1097/MJT.0000000000001433" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Pharmacology (medical)", "Pharmacology", "General Medicine" ], "subtitle": [], "title": "Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina", "type": "journal-article", "volume": "28" }